Analystreport

Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at Piper Sandler from $114.00 to $138.00.

Prometheus Biosciences, Inc.  (RXDX) 
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ignyta.com